# Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases

> **NCT03422432** · NA · COMPLETED · sponsor: **National Cancer Centre, Singapore** · enrollment: 17 (actual)

## Conditions studied

- Colorectal Cancer
- Peritoneal Metastases

## Interventions

- **PROCEDURE:** HIPEC

## Key facts

- **NCT ID:** NCT03422432
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-28
- **Primary completion:** 2023-09-07
- **Final completion:** 2024-12-13
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03422432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03422432, "Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03422432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*